Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity After SARS-CoV-2 Vaccination
View ORCID ProfileAlok R. Amraotkar, Adrienne M. Bushau-Sprinkle, View ORCID ProfileRachel J. Keith, Krystal T. Hamorsky, View ORCID ProfileKenneth E. Palmer, Hong Gao, View ORCID ProfileShesh N. Rai, View ORCID ProfileAruni Bhatnagar
doi: https://doi.org/10.1101/2022.03.15.22272432
Alok R. Amraotkar
1Division of Environmental Medicine, Christina Lee Brown Envirome Institute, University of Louisville School of Medicine, Louisville, KY, 40202 USA
Adrienne M. Bushau-Sprinkle
2Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville School of Medicine, Louisville, KY, 40202 USA
Rachel J. Keith
1Division of Environmental Medicine, Christina Lee Brown Envirome Institute, University of Louisville School of Medicine, Louisville, KY, 40202 USA
Krystal T. Hamorsky
2Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville School of Medicine, Louisville, KY, 40202 USA
Kenneth E. Palmer
2Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville School of Medicine, Louisville, KY, 40202 USA
Hong Gao
1Division of Environmental Medicine, Christina Lee Brown Envirome Institute, University of Louisville School of Medicine, Louisville, KY, 40202 USA
Shesh N. Rai
3Center for Integrative Environmental Health Sciences, University of Louisville School of Medicine, Louisville, KY, USA 40202
4Biostatistics and Bioinformatics Facility, Brown Cancer Centre, University of Louisville, Louisville, KY 40202, USA
5Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, KY 40202, USA
Aruni Bhatnagar
1Division of Environmental Medicine, Christina Lee Brown Envirome Institute, University of Louisville School of Medicine, Louisville, KY, 40202 USA
3Center for Integrative Environmental Health Sciences, University of Louisville School of Medicine, Louisville, KY, USA 40202
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Primary deidentified data supporting the findings of this study are available through the corresponding author (Aruni Bhatnagar: Aruni.bhatnagar{at}louisville.edu) upon request.
Posted August 01, 2022.
Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity After SARS-CoV-2 Vaccination
Alok R. Amraotkar, Adrienne M. Bushau-Sprinkle, Rachel J. Keith, Krystal T. Hamorsky, Kenneth E. Palmer, Hong Gao, Shesh N. Rai, Aruni Bhatnagar
medRxiv 2022.03.15.22272432; doi: https://doi.org/10.1101/2022.03.15.22272432
Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity After SARS-CoV-2 Vaccination
Alok R. Amraotkar, Adrienne M. Bushau-Sprinkle, Rachel J. Keith, Krystal T. Hamorsky, Kenneth E. Palmer, Hong Gao, Shesh N. Rai, Aruni Bhatnagar
medRxiv 2022.03.15.22272432; doi: https://doi.org/10.1101/2022.03.15.22272432
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12229)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2658)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3884)
- Nursing (209)
- Nutrition (578)
- Oncology (2032)
- Ophthalmology (585)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6529)
- Radiology and Imaging (1405)
- Respiratory Medicine (871)
- Rheumatology (410)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)